FDA is favorable on anti-anesthesia drug
(AP)
<p><a href="http://us.rd.yahoo.com/dailynews/rss/health/*http://news.yahoo.com/s/ap/20080307/ap_on_he_me/schering_drug_fda"><img src="http://d.yimg.com/us.yimg.com/p/nm/20080212/2008_02_12t074824_450x337_us_scheringplough.jpg?x=130&y=97&q=85&sig=UfyVceSEH0sGrWvzDI9YBg--" align="left" height="97" width="130" alt="Fred Hassan, CEO of Schering-Plough Corp., speaks at the Reuters Health Summit in New York, November 13, 2007. Schering-Plough Corp on Tuesday reported a quarterly loss as special charges from its acquisition of Organon Biosciences late last year offset sharply higher sales, but results beat Wall Street expectations. (Brendan McDermid/Reuters)" border="0" /></a>AP - Federal health regulators said Friday a Schering-Plough Corp. drug appears effective at helping patients recover from anesthesia, though some safety questions remain.</p><br clear="all"/>

Read more...